Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-006626
Filing Date
2025-03-04
Accepted
2025-03-04 17:30:45
Documents
1
Period of Report
2025-03-01

Document Format Files

Seq Description Document Type Size
1 form4-03042025_100342.html 4  
1 form4-03042025_100342.xml 4 3171
  Complete submission text file 0001415889-25-006626.txt   4512
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Issuer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address
O'Neill Shiv (Reporting) CIK: 0002001171 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38661 | Film No.: 25706750